Related Experiment Video
Updated: Feb 22, 2026

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Deceased Organ Donation From Pediatric Donors: Does the Literature Really Help Us? Implication for More Powerful
M Mojtabaee1, F Sadegh Beigee1, F Ghorbani2
1Lung Transplantation Research Center (LTRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Insights
Pediatric organ donors under 5 years require specialized management due to unique complications like hyperglycemia and acidosis. Despite these challenges, young donors remain a valuable resource for organ procurement.
Area of Science:
- Pediatric Organ Donation
- Critical Care Medicine
- Transplantation
Background:
- Brain-dead pediatric donors are crucial for organ transplantation.
- Donors under 5 years present unique management challenges not fully addressed in current guidelines.
Purpose of the Study:
- To compare the clinical characteristics and suitability for organ donation in brain-dead pediatric donors under 5 years versus those aged 5-12 years.
- To identify specific management needs for younger pediatric organ donors.
Main Methods:
- Retrospective analysis of 79 brain-dead pediatric donors.
- Donors categorized into two groups: under 5 years (Group A) and 5-12 years (Group B).
- Comparison of metabolic, hemodynamic, hematologic, and electrolyte status, and organ suitability.
Main Results:
- Younger donors (Group A) showed higher rates of hyperglycemia and respiratory acidosis.
- Older donors (Group B) had increased prevalence of anemia and coagulopathy.
- Group A required more high-dose inotropic support, yet organ yield was comparable between groups.
Conclusions:
- Donors under 5 years necessitate tailored management strategies due to distinct physiological complications.
- Despite management complexities, pediatric donors under 5 years represent a significant and valuable source for organ procurement.
Background:
Brain-dead pediatric donors have always been the focus of attention because of the higher quality, utility, and possibility of their organ donation. However, donors under the age of 5 years always necessitate making more challenging management efforts, which are not clearly implied in most parts of the guidelines.
Methods:
The data obtained from 79 brain-dead pediatric donors of the Organ Procurement Unit of Masih Daneshvari Hospital, Tehran, Iran, were assessed. The donors were divided into 2 groups, including donors under 5 years of age (group A) and those between 5 and 12 years of age (group B). Metabolic, hemodynamic, hematologic, and electrolyte status as well as the suitability for donation were compared in the study groups.
Results:
Of 1252 donors, 6.3% were under 12 years of age. Trauma and drug toxicity were the two primary causes of brain death in group A. In comparison, trauma and brain tumor were the leading causes of brain death in group B. The prevalence of both hyperglycemia and respiratory acidosis was significantly higher in group A (P < .05). However, severe anemia and coagulopathy were more prevalent in group B (P < .05). The high-dose inotropic administration was used for 42.4% of the donors in group A, whereas only 26% of the donors in group B needed a high dose of inotropes (P < .05). The mean quantity of organ harvested per donor was 2.1 and 2.25 in groups A and B, respectively. Furthermore, donor loss was not significantly different in both groups.
Conclusions:
The occurrence of different complications in donors under the age of 5 years requires special treatment considerations that should be the center of attention in the related guidelines. Organ donation per donor indicates that donors under the age of 5 years are a valuable resource for organ procurement.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

